prognosis based in a blood test

[frodo]

Clues to prognosis in multiple sclerosis found in the blood

https://www.nature.com/articles/s41582-020-0376-9

Neurofilament light (NfL) and microRNAs (miRNAs) can help to predict the course that multiple sclerosis (MS) will take for individuals, according to two new studies published in Neurology and Acta Neurologica Scandinavica. The markers could help to identify progressive disease and facilitate treatment decisions.

Most current MS treatments are used to minimize inflammatory activity in the relapsing–remitting form of the disease, yet it is disease progression in relapsing–remitting and progressive MS that ultimately leads to accumulation of disability. Reliable markers that identify patients with or at risk of progressive disease would, therefore, be valuable in clinical practice. In the new studies, two potential markers in the blood were investigated.